Blood Glucose Monitoring Systems - Global Market Outlook (2019-2027)
According to Stratistics MRC, the Global Blood Glucose Monitoring Systems Market is accounted for $9.45 billion in 2019 and is expected to reach $15.41 billion by 2027 growing at a CAGR of 6.3% during the forecast period. Increasing number of product launches and increasing prevalence of diabetes are the major factors propelling the market growth. However, factors such as strict regulations and decreased lab investments are hampering the market growth.
Blood glucose monitoring systems are diagnostics systems that are very essential for the care and treatment of diabetes, it is used to measure and monitor the levels of blood sugar in the patients. The significance of blood glucose monitoring system’s command is very high, with the growing prevalence of diabetes and diabetic population across the regions. These systems usually take blood samples, but with rising innovation and advancements in technology, even blood testing is considered traditional and sensors are deployed for continuous monitoring.
Based on the patient care setting, the self/home care segment is going to have a huge demand owing to rising diabetic population, and increasing consciousness about regular monitoring of glucose levels and increasing product launches enhancing patient comfort when used at home. By geography, North America is estimated to have a lucrative growth in the forecast period. The growth is mainly attributed by growing prevalence of diabetes in the US and Canada, favorable reimbursements, awareness programs.
Some of the key players profiled in the Blood Glucose Monitoring Systems Market include Abbott, Ascensia Diabetes Care Holdings AG, Braun Melsungen AG, Dexcom, Inc., DiamonTech GmbH, Hoffmann-La Roche Ltd., Lifescan Inc., Medtronic, Terumo Medical Corporation, Ypsomed, Nipro, Sanofi, Arkray, Acon Laboratories and Prodigy Diabetes Care.
• Non- Wearable
Distribution Channels Covered:
• Retail Sales
• Institutional Sales
• Self-monitoring of Blood Glucose Monitoring Systems
• Continuous Blood Glucose Monitoring Systems
Testing Sites Covered:
• Alternate Site Testing
• Fingertip testing
Patient Care Settings Covered:
• Hospital & Clinics
• Self/Home Care
• Gestational Diabetes
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliance
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.